pictures
-
Biologics
Smith & Nephew Biologics new Joint Venture with Essex Woodlands – An Interview with Mark Augusti
We recently heard the news about Smith & Nephew selling 51% of their Biologics division to Essex Woodlands in a…
Read More » -
Hospitals
Sunshine Act data collection delayed to January 2013, says USA’s CMS
In a web site posting last week, The US Center for Medicare and Medicaid Services (CSM) announced that manufacturers will…
Read More » -
Recon
How To Design a Safer, Longer-Lasting Artificial Hip
Artificial hip replacements can provide a lifetime of pain-free mobility to many patients, but due to the constant movement of…
Read More » -
Biologics
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
DSM will commence all-cash tender offer in May Tender Offer expected to be completed by June 30, 2012 EXTON, Pa., May…
Read More » -
Spine
CEO charged with overbilling for spinal implants
Prosecutors say a San Francisco-based firm drastically overbilled taxpayers for government employee spinal implants. Santa Clara County prosecutors filed fraud…
Read More » -
Sports Medicine
Orthofix sells Breg sports medicine unit to PE firm for $158M cash
April 24, 2012 by MassDevice staff Orthofix sells its sports medicine subsidiary Breg Inc. to private equity subsidiary Breg Acquisition Corp. for…
Read More » -
Extremities
J&J Wins EU Approval for $21.3 Billion Synthes Acquisition
Johnson & Johnson (JNJ) won European Union approval for its $21.3 billion purchase ofSynthes Inc. (SYST) after agreeing to sell its DePuy…
Read More » -
Recon
Orthopedic survey: U.S. knee/hip market has hit bottom
A survey of orthopedic docs by investment bank Leerink Swann yields mixed messages for the U.S. market for hip and…
Read More » -
Spine
Michael Will, Entrepreneur and Executive, Has Died
Michael Will, 56 years old, president of Centinel Spine, former CEO and president of Pegasus Biologics and senior vice president…
Read More » -
Uncategorized
CEO Interview Series, Greg Rainey from CCI Performance
We have started a new interview series where we will be speaking one on one with the senior leaders in…
Read More » -
Extremities
Former Synthes sales rep counter-sues in generic ortho devices battle
April 6, 2012 by MassDevice staff Former Synthes sales rep turned Emerge Medical CEO John Marotta filed a countersuit against the med-tech…
Read More » -
Extremities
Biomet Announces Offer to Acquire DePuy Trauma Business
WARSAW, Ind.–(BUSINESS WIRE)–Biomet, Inc. a global leader in the manufacture of musculoskeletal medical products, announced today that it has made…
Read More » -
Uncategorized
Say it Ain’t So – Globus Medical Files For Estimated $100M IPO
DOW JONES NEWSWIRES Medical device maker Globus Medical Inc. filed plans to raise up to $100 million in an initial…
Read More » -
Uncategorized
Commentary from Walter Eisner (RYOrtho.com) on Biomet’s DPA
The U.S. Department of Justice’s Criminal Division (DOJ) announced on March 26, that Biomet, Inc. has entered into a deferred…
Read More » -
Recon
Biomet Pays $22 Million In Latest Medical Device Bribery Settlement
By C.M. Matthews Orthopedic manufacturer Biomet Inc. agreed to pay more than $22 million in penalties Monday to settle charges that it…
Read More »